| Title |
Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC)
|
|---|---|
| Published in |
Journal of Cancer Research and Clinical Oncology, November 2014
|
| DOI | 10.1007/s00432-014-1864-3 |
| Pubmed ID | |
| Authors |
Leonard Christopher Schmeel, Frederic Carsten Schmeel, Christoph Coch, Ingo G. H. Schmidt-Wolf |
| Abstract |
Cytokine-induced killer (CIK) cells represent an exceptional T cell population uniting a T cell and natural killer cell like phenotype in their terminally differentiated CD3(+)CD56(+) subset, which features non-MHC-restricted tumor-killing activity. CIK cells are expandable from peripheral blood mononuclear cells and mature following the addition of certain cytokines. CIK cells have provided encouraging results in initial clinical studies and revealed synergistic antitumor effects when combined with standard therapeutic procedures. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 3 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 97 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 97 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 20 | 21% |
| Student > Master | 17 | 18% |
| Student > Ph. D. Student | 10 | 10% |
| Student > Bachelor | 8 | 8% |
| Other | 4 | 4% |
| Other | 10 | 10% |
| Unknown | 28 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 19 | 20% |
| Agricultural and Biological Sciences | 13 | 13% |
| Medicine and Dentistry | 13 | 13% |
| Immunology and Microbiology | 11 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 4% |
| Other | 5 | 5% |
| Unknown | 32 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 July 2023.
All research outputs
#2,514,424
of 23,815,455 outputs
Outputs from Journal of Cancer Research and Clinical Oncology
#73
of 2,632 outputs
Outputs of similar age
#30,302
of 264,912 outputs
Outputs of similar age from Journal of Cancer Research and Clinical Oncology
#1
of 22 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,632 research outputs from this source. They receive a mean Attention Score of 3.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 264,912 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.